2020
Impact Factor
6.745

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19

PDF(1011 KB)
Aging and disease ›› 2021, Vol. 12 ›› Issue (2) : 360-370. DOI: 10.14336/AD.2020.1218
Orginal Article

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

RIS Export
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 12(2): 360-370 https://doi.org/10.14336/AD.2020.1218

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1011 KB)

Accesses

Citation

Detail

Sections
Recommended

/